The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus (Q33891620)

29 July 2017

1 reference

title

The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus (English)

1 reference

29 July 2017

0 references

Kahn SE

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

American Journal of Medicine

29 July 2017

published in

1 reference

29 July 2017

volume

108 Suppl 6a

1 reference

29 July 2017

page(s)

2S-8S

1 reference

Immunoassay of endogenous plasma insulin in man

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

The Significance of Basal Insulin Levels in the Evaluation of the Insulin Response to Glucose in Diabetic and Nondiabetic Subjects*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Pathophysiology of Insulin Secretion in Non-insulin-dependent Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Insulin secretion in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

INSULIN DEFICIENCY IN NON-INSULIN-DEPENDENT DIABETES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Relationship of proinsulin and insulin to cardiovascular risk factors in nondiabetic subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Proinsulin as a marker for the development of NIDDM in Japanese-American men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Amyloid and polypeptide hormones: What is their interrelationship?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900336-3

10.1016/S0002-9343(00)00336-3

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference